Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

PURPOSE: A randomized, placebo-controlled study based on preclinical and clinical data that supports the potential role of vascular endothelial growth factor in prostate cancer was performed to evaluate the addition of bevacizumab to standard docetaxel and prednisone therapy in patients with metasta...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kelly, William Kevin, Halabi, Susan, Carducci, Michael, George, Daniel, Mahoney, John F., Stadler, Walter M., Morris, Michael, Kantoff, Philip, Monk, J. Paul, Kaplan, Ellen, Vogelzang, Nicholas J., Small, Eric J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2012
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383121/
https://ncbi.nlm.nih.gov/pubmed/22454414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.4767
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki